Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.50 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.49 |
| ▸ | HCAR3 | P49019 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11052022 | 0.87 | PTPN1 (0.58) | CASP6ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL23909538 | 0.86 | ALDH1A1 (0.54) | CASP6ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7061043 | 0.86 | ALDH1A1 (0.54) | ALDH1A1MEN1KMT2ATSHRLMNA | |
| SCHEMBL30714879 | 0.82 | CASP6 (0.64) | CASP6MEN1KMT2ATSHRLMNA | |
| SCHEMBL8960516 | 0.82 | CASP6 (0.64) | CASP6MEN1KMT2ATSHRLMNA | |
| SCHEMBL772810 | 0.79 | CDK2 (0.55) | CASP6ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL30399151 | 0.79 | CDK2 (0.55) | CASP6ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7061209 | 0.79 | KMT2A (0.58) | ALDH1A1MEN1KMT2ALMNAPOLB | |
| SCHEMBL26885179 | 0.79 | HTT (0.55) | ALDH1A1MEN1KMT2ALMNAHCAR3 | |
| SCHEMBL11054419 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2ATSHRAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| EP-3801880-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF | Desiccant Rotors International Private Ltd. (IN) | 2021-04-14 | — | — | EP | claimed |
| US-20210016245-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFs), COVALENT ORGANIC FRAMEWORKS (COFs) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFs), AND APPLICATIONS THEREOF | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2021-01-21 | — | — | US | claimed |
| US-20200291045-A1 | CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-09-17 | — | — | US | claimed |
| EP-2739169-B1 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-06-12 | — | — | EP | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| CN-100497441-C | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2009-06-10 | — | — | CN | claimed |
| CN-1289504-C | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1616462-A | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1616521-A | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | claimed |
| US-20240197868-A1 | IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2024-06-20 | — | — | US | disclosed |
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | disclosed |
| EP-4313133-A2 | IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS | UNIVERSITE DE VERSAILLES-SAINT QUENTIN EN YVELINES (FR) | 2024-02-07 | — | — | EP | disclosed |
| US-11891406-B2 | Conductivity enhancement of MOFs via development of MOFpolymer composite material | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-02-06 | — | — | US | disclosed |
| US-20020035137-A1 | Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors | ABBOTT LABORATORIES | 2002-03-21 | — | — | US | disclosed |
| WO-2002018323-A2 | AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS | ABBOTT LABORATORIES (US) | 2002-03-07 | — | — | WO | disclosed |
| US-4490370-A | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0122155-A2 | Improvements in or relating to naphthylglycyl cephalosporin derivatives | ELI LILLY AND COMPANY (US) | 1984-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035137-A1 | Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors | PPM1A, PTPRO, PTP4A1 | CASP6 4189/4885ALDH1A1 299/4885MEN1 3065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.